Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

2.8K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.8K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

3.9K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.9K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

8.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.6K
Disorders of Hemostasis01:24

Disorders of Hemostasis

2.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K
Inflammation01:38

Inflammation

61.5K
Overview
61.5K
Disorders of Leukocytes01:27

Disorders of Leukocytes

1.8K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Genomic features do not account for differences in multiple myeloma risk by ancestry.

Blood cancer discovery·2026
Same author

A differentiated effector T cell repertoire defines a functionally high-risk group of smoldering myeloma patients.

Blood cancer journal·2026
Same author

Development of CAR T cells Targeting a Surface RNA Binding Protein for the Treatment of Acute Leukemias.

Cancer discovery·2026
Same author

Diabetes mellitus in multiple myeloma and related plasma cell disorders: a review of risk, prognosis, and outcomes.

Blood cancer journal·2026
Same author

Outstanding Questions to Understand and Target Splicing Factor-Mutant Blood Cancers.

Blood cancer discovery·2026
Same author

Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma.

Blood cancer journal·2026
Same journal

BTK Degraders in Lymphoid Malignancies: New Modality, New Resistance Rules?

Blood cancer discovery·2026
Same journal

Tumor-infiltrating clonal hematopoiesis is associated with adverse clinical outcomes in diffuse large B-cell lymphoma.

Blood cancer discovery·2026
Same journal

Beyond Static Subtypes in Large B-cell Lymphoma: Context, Plasticity, and Therapeutic Logic.

Blood cancer discovery·2026
Same journal

A Patient-Derived Xenograft Repository Capturing Clinical and Molecular Heterogeneity of Large B-cell Lymphoma.

Blood cancer discovery·2026
Same journal

Outcomes of CAR-T Cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma.

Blood cancer discovery·2026
See all related articles

Related Experiment Video

Updated: Jan 11, 2026

Proplatelet Formation Dynamics of Mouse Fresh Bone Marrow Explants
05:58

Proplatelet Formation Dynamics of Mouse Fresh Bone Marrow Explants

Published on: May 20, 2021

2.9K

The Link between Modifiable Risk Factors and Myeloid Disorders-From Plate to Pathogenesis.

Joshua T Weinreb1, Omar Abdel-Wahab1, Urvi A Shah1

  • 1Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York.

Blood Cancer Discovery
|November 12, 2025
PubMed
Summary
This summary is machine-generated.

Lifestyle interventions may impact myeloid disorders like clonal hematopoiesis, myelodysplastic syndromes, and acute myeloid leukemia by targeting inflammation. Further research is needed to confirm these effects on disease progression.

More Related Videos

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

989
Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
09:46

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Published on: December 27, 2017

20.4K

Related Experiment Videos

Last Updated: Jan 11, 2026

Proplatelet Formation Dynamics of Mouse Fresh Bone Marrow Explants
05:58

Proplatelet Formation Dynamics of Mouse Fresh Bone Marrow Explants

Published on: May 20, 2021

2.9K
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

989
Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
09:46

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Published on: December 27, 2017

20.4K

Area of Science:

  • Hematology
  • Oncology
  • Preventive Medicine

Background:

  • Myeloid disorders, including clonal hematopoiesis of indeterminate potential, myelodysplastic syndromes, and acute myeloid leukemia, are linked to inflammation and metabolic issues.
  • Obesity, insulin resistance, diet, and smoking are modifiable risk factors associated with myeloid disorder pathogenesis.

Purpose of the Study:

  • To review the association between myeloid disorders, inflammation, and modifiable risk factors.
  • To explore the potential of lifestyle interventions in influencing myeloid disorder progression.

Main Methods:

  • Literature review of myeloid disorders, inflammation, and modifiable risk factors.
  • Analysis of the potential impact of lifestyle interventions on disease pathways.

Main Results:

  • Myeloid disorders are associated with inflammation and metabolic dysfunction.
  • Modifiable factors like diet and exercise may influence disease pathogenesis and survival.
  • No ongoing clinical trials evaluate lifestyle interventions for myeloid disorder progression.

Conclusions:

  • Lifestyle modifications may offer a strategy to influence myeloid disorder pathogenesis by addressing inflammatory and metabolic pathways.
  • Further preclinical research and clinical trials are essential to validate these findings.
  • Understanding modifiable factors can guide future research to reduce the burden of myeloid disorders.